ADC Therapeutics SA (ADC)

Oncology Corporate Profile

HQ Location

Route de la Corniche 3B
1066 Epalinges,
Switzerland,

Company Description

ADC Therapeutics SA (ADCT) is an oncology drug development company that specializes in the development of proprietary ADCs targeting major solid and hematological cancers. The Company’s ADCs are highly targeted drug constructs which combine monoclonal antibodies specific to surface antigens present on particular tumor cells with a novel class of highly potent pyrrolobenzodiazepine (PBD)-based warheads.

Website: http://www.adctherapeutics.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
ADCT-402anti-CD19 monoclonal antibody (surface antigen specific for B cells)Acute Lymphocytic Leukemia (ALL)I
ADCT-301anti-CD19 monoclonal antibody (surface antigen specific for B cells)Acute Myelogenous Leukemia (AML)I
ADCT-502anti-CD19 monoclonal antibody (surface antigen specific for B cells)Bladder cancerI
ADCT-502anti-CD19 monoclonal antibody (surface antigen specific for B cells)BreastI
ADCT-501anti-CD19 monoclonal antibody (surface antigen specific for B cells)Breast cancerI
ADCT-502anti-CD19 monoclonal antibody (surface antigen specific for B cells)Gastric cancerI
ADCT-402anti-CD19 monoclonal antibody (surface antigen specific for B cells)Non-Hodgkin's Lymphoma (NHL)I
ADCT-301anti-CD19 monoclonal antibody (surface antigen specific for B cells)Non-Hodgkin's Lymphoma (NHL)I
ADCT-401anti-CD19 monoclonal antibody (surface antigen specific for B cells)Prostate cancerI
ADCT-601anti-CD19 monoclonal antibody (surface antigen specific for B cells)Various cancer typesI

View additional information on product candidates here »

Source


http://www.adctherapeutics.com/

Recent News Headlines

Agree Realty Announces First Quarter 2017 Earnings Release Date and Conference Call Information

3/27/2017 08:00 pm

[PR Newswire] - BLOOMFIELD HILLS, Mich., March 27, 2017 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that it will release its first quarter 2017 operating results after ...

Agree Realty Declares Quarterly Cash Dividend

2/28/2017 09:00 pm

[PR Newswire] - BLOOMFIELD HILLS, Mich., Feb. 28, 2017 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") announced today that its Board of Directors has authorized, and the Company has declared, ...

Agree Realty Corporation Reports Fourth Quarter And Full Year 2016 Results

2/23/2017 09:00 pm

[PR Newswire] - BLOOMFIELD HILLS, Mich., Feb. 23, 2017 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced results for the quarter and full year ended December 31, 2016. All ...

Agree Realty Announces Fourth Quarter 2016 Earnings Release Date and Conference Call Information

1/18/2017 09:00 pm

[PR Newswire] - BLOOMFIELD HILLS, Mich., Jan. 18, 2017 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that it will release its fourth quarter and full year 2016 operating ...

Agree Realty Announces Record 2016 Investment Activity And Provides 2017 Guidance

1/5/2017 09:05 pm

[at noodls] - 70 E. Long Lake Rd. Bloomfield Hills, MI 48304 www.agreerealty.com FOR IMMEDIATE RELEASE AGREE REALTY ANNOUNCES RECORD 2016 INVESTMENT ACTIVITY AND PROVIDES 2017 GUIDANCE Bloomfield Hills, MI, January ...

Agree Realty Announces Record 2016 Investment Activity And Provides 2017 Guidance

1/5/2017 09:00 pm

[PR Newswire] - BLOOMFIELD HILLS, Mich., Jan. 5, 2017 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced a summary of its record investment activity in 2016 and provided acquisition ...

Agree Realty Declares Increased Quarterly Cash Dividend

12/6/2016 09:00 pm

[PR Newswire] - BLOOMFIELD HILLS, Mich., Dec. 6, 2016 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") announced today that its Board of Directors has authorized, and the Company has declared, ...